Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 5.72% |
| Q2 2025 | 23.54% |
| Q1 2025 | 38.74% |
| Q4 2024 | 47.45% |
| Q3 2024 | -5.68% |
| Q2 2024 | -1.23% |
| Q1 2024 | 4.57% |
| Q4 2023 | 17.20% |
| Q3 2023 | -10.75% |
| Q2 2023 | -6.28% |
| Q1 2023 | 9.59% |
| Q4 2022 | -36.44% |
| Q3 2022 | -2.39% |
| Q2 2022 | -0.78% |
| Q1 2022 | -24.54% |
| Q4 2021 | -5.34% |
| Q3 2021 | -7.15% |
| Q2 2021 | -54.32% |
| Q1 2021 | -18.75% |
| Q4 2020 | -22.74% |
| Q3 2020 | -228.46% |
| Q2 2020 | -77.74% |
| Q1 2020 | -13.43% |
| Q4 2019 | 27.23% |
| Q3 2019 | -9.76% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |